Literature DB >> 19460106

The effects of butyrate enemas on visceral perception in healthy volunteers.

S A L W Vanhoutvin1, F J Troost, T O C Kilkens, P J Lindsey, H M Hamer, D M A E Jonkers, K Venema, R-J M Brummer.   

Abstract

Fermentation of dietary fibres by colonic microbes leads to the production of short chain fatty acids (mainly propionate, butyrate and acetate), which are utilized by the colonic mucosa. Previous studies showed positive effects of butyrate on parameters of oxidative stress, inflammation and apoptosis. Recent studies in rats, however, showed that butyrate increased visceral sensitivity. The aim of this study was to determine the effects of physiologically relevant concentrations of butyrate on visceral perception in healthy human subjects. Eleven healthy volunteers participated in this randomized double-blind, placebo controlled cross-over study. The study consisted of three periods of 1 week each, in which the volunteers daily self-administered rectal enemas containing 100, 50 mmol L(-1) butyrate, or placebo (saline) prior to sleeping. A rectal barostat measurement was performed at the start and the end of each test period for the measurement of pain, urge and discomfort. Butyrate treatment resulted in a dose-dependent reduction of pain, urge and discomfort throughout the entire pressure range of the protocol. At a pressure of 4 mmHg, 50 and 100 mmol L(-1) butyrate concentrations resulted in a 23.9% and 42.1% reduction of pain scores, respectively, and the discomfort scores decreased by 44.2% and 69.0% respectively. At a pressure of 67 mmHg, 50 and 100 mmol L(-1) of butyrate decreased the pain scores by 23.8% and 42%, respectively, and discomfort scores 1.9% and 5.2% respectively. Colonic administration of butyrate, at physiologically relevant concentrations, dose-dependently decreases visceral sensitivity in healthy volunteers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460106     DOI: 10.1111/j.1365-2982.2009.01324.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  51 in total

1.  Tools for the tract: understanding the functionality of the gastrointestinal tract.

Authors:  Petia Kovatcheva-Datchary; Erwin G Zoetendal; Koen Venema; Willem M de Vos; Hauke Smidt
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 2.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

Review 3.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone; Monica Pedata; Rosaria Meli; Antonio Calignano
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

4.  Controversies and Recent Developments of the Low-FODMAP Diet.

Authors:  Peta Hill; Jane G Muir; Peter R Gibson
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-01

Review 5.  Role of Neurochemicals in the Interaction between the Microbiota and the Immune and the Nervous System of the Host Organism.

Authors:  Alexander V Oleskin; Boris A Shenderov; Vladimir S Rogovsky
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

6.  Increasing Symptoms in Irritable Bowel Symptoms With Ingestion of Galacto-Oligosaccharides Are Mitigated by α-Galactosidase Treatment.

Authors:  C J Tuck; K M Taylor; P R Gibson; J S Barrett; J G Muir
Journal:  Am J Gastroenterol       Date:  2017-08-15       Impact factor: 10.864

7.  Colonic butyrate- algesic or analgesic?

Authors:  P Kannampalli; R Shaker; J N Sengupta
Journal:  Neurogastroenterol Motil       Date:  2011-11       Impact factor: 3.598

Review 8.  Brain-gut microbiome interactions and functional bowel disorders.

Authors:  Emeran A Mayer; Tor Savidge; Robert J Shulman
Journal:  Gastroenterology       Date:  2014-02-28       Impact factor: 22.682

9.  Caecal pH is a biomarker of excessive colonic fermentation.

Authors:  Adam D Farmer; Sahar D Mohammed; George E Dukes; S Mark Scott; Anthony R Hobson
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

Review 10.  The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.

Authors:  Christian Milani; Sabrina Duranti; Francesca Bottacini; Eoghan Casey; Francesca Turroni; Jennifer Mahony; Clara Belzer; Susana Delgado Palacio; Silvia Arboleya Montes; Leonardo Mancabelli; Gabriele Andrea Lugli; Juan Miguel Rodriguez; Lars Bode; Willem de Vos; Miguel Gueimonde; Abelardo Margolles; Douwe van Sinderen; Marco Ventura
Journal:  Microbiol Mol Biol Rev       Date:  2017-11-08       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.